Out Of The Blocks, September 2014
Brief profiles of these recently formed life science companies: Flex Pharma, Harpoon Medical, Integene, Nirmidas Biotech, and Predemtec.
You may also be interested in...
Years after a scathing Indian parliamentary report flagged concerns around regulatory lapses for drug approvals, an expert panel has endorsed the continued marketing of ambrisentan and everolimus in the country. But dronedarone, also featured in the report, is no longer sold by Sanofi in India.